|drug1982||Medical Record Review Wiki||1.00|
|drug1704||Intervention training: Wiki||1.00|
|drug3626||VitalTalk communication skills training Wiki||1.00|
|D058186||Acute Kidney Injury NIH||0.21|
|D014947||Wounds and Injuries NIH||0.18|
There is one clinical trial.
This Pre-Post, open-cohort design, pragmatic trial with 150 clinicians and will evaluate the effectiveness of the use of telehealth Advanced Care Planning (ACP) Program by comparing ACP documentation among 13,000 patients over 65
Description: This study tests the effects of an ACP Program that trains clinicians and provides patients with a video decision aid on rates of ACP among 13,000 patients at risk, or with, COVID-19. All patients over 65 engaged with the enrolled clinics over the course of each time period in each of the three study periods will be included in the analysis. Rates of ACP are determined by natural language processing data extraction of electronic health records. Generalized linear mixed models will be used to compare outcomes between intervention and control periods.Measure: Rate for Advanced Care Planning (ACP) documentation Time: 2 Years
Description: Same methodology as Primary OutcomeMeasure: Rate of orders for resuscitation preferences Time: 2 years
Description: Same methodology as Primary OutcomeMeasure: Rate of palliative care consultation Time: 2 years
Description: Same methodology as Primary OutcomeMeasure: Rate of referral to hospice Time: 2 years
Description: The analysis will use a difference in differences approach comparing the changes from the control period to the intervention period between White and non-White racial minority and between non-Medicaid and Medicaid patients.Measure: Advanced Care Planning (ACP) documentation rates among under-represented minority groups. Time: 2 Years
Data processed on January 01, 2021.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports